Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical EBIT 2010-2024 | TAK

Takeda Pharmaceutical annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Takeda Pharmaceutical EBIT for the quarter ending June 30, 2024 was $1.065B, a 13.5% decline year-over-year.
  • Takeda Pharmaceutical EBIT for the twelve months ending June 30, 2024 was $1.311B, a 64.58% decline year-over-year.
  • Takeda Pharmaceutical 2024 annual EBIT was $1.477B, a 59.31% decline from 2023.
  • Takeda Pharmaceutical 2023 annual EBIT was $3.63B, a 11.5% decline from 2022.
  • Takeda Pharmaceutical 2022 annual EBIT was $4.102B, a 82.53% decline from 2021.
  
Takeda Pharmaceutical Annual EBIT
(Millions of US $)
2024 $1,477
2023 $3,630
2022 $4,102
2021 $23,480
2020 $924
2019 $1,845
2018 $2,176
2017 $1,450
2016 $1,086
2015 $-1,176
2014 $1,393
2013 $1,482
2012 $3,366
2011 $4,423
2010 $4,518
2009 $-4,623
Takeda Pharmaceutical Quarterly EBIT
(Millions of US $)
2024-06-30 $1,065
2024-03-31 $-126
2023-12-31 $713
2023-09-30 $-340
2023-06-30 $1,231
2023-03-31 $675
2022-12-31 $1,044
2022-09-30 $752
2022-06-30 $1,159
2022-03-31 $-72
2021-12-31 $1,025
2021-09-30 $887
2021-06-30 $2,262
2021-03-31 $20,096
2020-12-31 $1,374
2020-09-30 $454
2020-06-30 $1,556
2020-03-31 $-34
2019-12-31 $492
2019-09-30 $376
2019-06-30 $90
2018-12-31 $1,001
2018-06-30 $910
2017-06-30 $1,755
2016-06-30 $1,422
2015-06-30 $406
2015-03-31 $3,673
2014-12-31 $-10,919
2014-09-30 $4,076
2014-06-30 $612
2014-03-31 $3,982
2013-12-31 $4,528
2013-09-30 $4,222
2013-06-30 $509
2013-03-31 $3,722
2012-12-31 $4,959
2012-09-30 $4,936
2012-06-30 $892
2012-03-31 $4,816
2011-12-31 $5,484
2011-09-30 $4,454
2011-03-31 $4,113
2010-03-31 $3,728
2009-09-30 $2
2009-03-31 $3,594
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $47.155B $28.196B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $89.015B 35.47
Merck (MKGAF) Germany $23.651B 25.81
Astellas Pharma (ALPMY) Japan $22.060B 26.50
Summit Therapeutics (SMMT) United States $17.795B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.649B 0.00
United Therapeutics (UTHR) United States $15.242B 15.74
Shionogi (SGIOY) Japan $13.107B 12.56
Neurocrine Biosciences (NBIX) United States $12.102B 36.21
Catalent (CTLT) United States $10.946B 0.00
Orion OYJ (ORINY) Finland $7.423B 30.23
Revolution Medicines (RVMD) United States $7.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.766B 7.18
Ionis Pharmaceuticals (IONS) United States $6.194B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.063B 0.00
Corcept Therapeutics (CORT) United States $4.417B 37.41
Crinetics Pharmaceuticals (CRNX) United States $4.223B 0.00
Dyne Therapeutics (DYN) United States $3.448B 0.00
PTC Therapeutics (PTCT) United States $2.729B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.696B 15.55
Arrowhead Pharmaceuticals (ARWR) United States $2.583B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.425B 19.27
Soleno Therapeutics (SLNO) United States $2.082B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.942B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.780B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.647B 0.00
Xencor (XNCR) United States $1.625B 0.00
Harrow (HROW) United States $1.608B 0.00
Cassava Sciences (SAVA) United States $1.455B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.436B 0.00
Ocular Therapeutix (OCUL) United States $1.411B 0.00
Ardelyx (ARDX) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Indivior (INDV) United States $1.347B 6.18
Avadel Pharmaceuticals (AVDL) Ireland $1.314B 0.00
Evotec AG (EVO) Germany $1.290B 0.00
Collegium Pharmaceutical (COLL) United States $1.249B 7.17
Calliditas Therapeutics AB (CALT) Sweden $1.200B 0.00
Enliven Therapeutics (ELVN) United States $1.028B 0.00
Relay Therapeutics (RLAY) United States $1.015B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.013B 0.00
Bioventus (BVS) United States $0.947B 30.76
4D Molecular Therapeutics (FDMT) United States $0.874B 0.00
Cronos Group (CRON) Canada $0.868B 0.00
USANA Health Sciences (USNA) United States $0.759B 13.92
Savara (SVRA) United States $0.731B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.722B 45.20
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.676B 6.40
Exscientia (EXAI) United Kingdom $0.631B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.594B 0.00
Siga Technologies (SIGA) United States $0.569B 6.81
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
OmniAb (OABI) United States $0.545B 0.00
Tourmaline Bio (TRML) United States $0.538B 0.00
Eliem Therapeutics (ELYM) United States $0.535B 0.00
Foghorn Therapeutics (FHTX) United States $0.529B 0.00
Altimmune (ALT) United States $0.528B 0.00
Verve Therapeutics (VERV) United States $0.466B 0.00
Sage Therapeutics (SAGE) United States $0.463B 0.00
KalVista Pharmaceuticals (KALV) United States $0.462B 0.00
Aquestive Therapeutics (AQST) United States $0.451B 0.00
Larimar Therapeutics (LRMR) United States $0.437B 0.00
Xeris Biopharma Holdings (XERS) United States $0.432B 0.00
Elite Pharmaceuticals (ELTP) United States $0.414B 38.75
Zevra Therapeutics (ZVRA) United States $0.412B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Aldeyra Therapeutics (ALDX) United States $0.349B 0.00
Lyell Immunopharma (LYEL) United States $0.346B 0.00
Korro Bio (KRRO) United States $0.342B 0.00
Esperion Therapeutics (ESPR) United States $0.341B 0.00
Lexeo Therapeutics (LXEO) United States $0.317B 0.00
Heron Therapeutics (HRTX) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.284B 0.00
Avita Medical (RCEL) United States $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.251B 17.14
Enanta Pharmaceuticals (ENTA) United States $0.241B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.240B 0.00
Acrivon Therapeutics (ACRV) United States $0.234B 0.00
Nanobiotix S.A (NBTX) France $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.232B 0.00
Pyxis Oncology (PYXS) United States $0.216B 0.00
CytoDyn (CYDY) United States $0.199B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.196B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
Context Therapeutics (CNTX) United States $0.147B 0.00
Century Therapeutics (IPSC) United States $0.140B 0.00
Prelude Therapeutics (PRLD) United States $0.134B 0.00
OptiNose (OPTN) United States $0.128B 0.00
Fractyl Health (GUTS) United States $0.128B 0.00
Assertio Holdings (ASRT) United States $0.124B 21.67
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Journey Medical (DERM) United States $0.106B 0.00
Regulus Therapeutics (RGLS) United States $0.106B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
CASI Pharmaceuticals (CASI) China $0.105B 0.00
Metagenomi (MGX) United States $0.100B 0.00
Citius Pharmaceuticals (CTXR) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.092B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Vivani Medical (VANI) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Inotiv (NOTV) United States $0.048B 0.00
ProPhase Labs (PRPH) United States $0.047B 0.00
FibroGen (FGEN) United States $0.042B 0.00
DURECT (DRRX) United States $0.042B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Protara Therapeutics (TARA) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Tempest Therapeutics (TPST) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.031B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
BioVie (BIVI) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Talphera (TLPH) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.015B 0.00
Indaptus Therapeutics (INDP) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.48
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.56